Advancing Scientific Leadership, Rare Disease Innovation, and Patient-Centered Medical Affairs Excellence
Zambon has announced the appointment of Erin Edwards as Director, US Medical Affairs, reinforcing the company’s commitment to advancing scientific innovation, strengthening medical strategy, and improving outcomes for patients living with rare and complex neurological diseases.
With a career that uniquely combines clinical neuroscience research, translational medicine, medical affairs leadership, and scientific engagement, Erin Edwards has established herself as a respected leader capable of bridging groundbreaking research with real-world patient care. Her experience spans pharmaceutical medical affairs, neuroscience research, publication strategy, key opinion leader (KOL) engagement, evidence generation, and cross-functional collaboration across both commercial and clinical organizations.
Her appointment reflects Zambon’s continued investment in strengthening its medical affairs organization as it advances innovative therapies designed to address significant unmet medical needs.
Leading the Next Chapter of US Medical Affairs at Zambon
As Director, US Medical Affairs, Erin Edwards will lead the strategic direction of Zambon’s U.S. medical organization, ensuring that scientific excellence remains at the center of every stage of product development and commercialization.
Her leadership responsibilities include driving:
- Medical affairs strategy across therapeutic portfolios
- Scientific communication and medical education
- KOL engagement and advisory board leadership
- Evidence generation and publication planning
- Cross-functional collaboration with clinical, commercial, regulatory, and patient advocacy teams
- Medical insight generation to guide development strategies
- Field Medical leadership and organizational capability building
- Launch readiness for innovative therapies
Her appointment comes as healthcare organizations increasingly rely on scientific leadership to ensure that emerging therapies deliver measurable value for physicians, healthcare systems, and patients alike.
Building Medical Affairs Excellence at Zambon
Before assuming her current leadership role, Erin served as Associate Medical Director – Lead of US Medical Affairs, where she played a central role in shaping the company’s medical strategy across multiple therapeutic areas.
Her responsibilities included leadership across:
- Rare disease programs
- Emerging therapeutic platforms
- First-in-class medicines
- Pre-launch medical strategy
- Scientific data dissemination
- Target Product Profile development
- Clinical narrative creation
- Business development support
She also oversaw the Field Medical organization, leading initiatives focused on:
- Stakeholder mapping
- Medical engagement planning
- Scientific exchange
- Medical insight collection
- Medical Science Liaison (MSL) development
- Publication strategy
- Real-world evidence generation
Working closely with global clinical development teams, regulatory leaders, commercial organizations, and patient advocacy groups, Erin helped ensure that scientific rigor remained central throughout product development and launch planning.
Scientific Engagement as Senior Medical Science Liaison
Prior to joining medical leadership, Erin served as both Senior Medical Science Liaason and Medical Science Liaison at Zambon.
In these roles, she strengthened relationships with leading healthcare professionals while translating highly complex scientific data into meaningful clinical conversations.
Her work included:
- Scientific exchange with physicians
- Therapeutic education
- Clinical evidence discussions
- Field insight collection
- Medical strategy execution
- KOL relationship development
- Support for emerging therapies
Her ability to transform scientific complexity into practical clinical value established her as a trusted partner among healthcare professionals.
Strengthening Multiple Sclerosis Medical Affairs at Bristol Myers Squibb
Before joining Zambon, Erin served as Medical Science Liaison at Bristol Myers Squibb, supporting the Multiple Sclerosis portfolio, including post-launch and Phase IV activities for Zeposia.
Her responsibilities focused on:
- Scientific engagement with neurologists
- Real-world evidence discussions
- Medical education
- Clinical data interpretation
- Evidence-based treatment conversations
- KOL collaboration
One of her notable achievements involved expanding scientific coverage across the Northeastern United States, increasing territory reach by 50% while improving access to medical education in rural and underserved regions across Maine, New Hampshire, Vermont, and New York.
Her work demonstrated a strong commitment to improving equitable access to neurological innovation.
A Distinguished Foundation in Neuroscience Research
Before entering the pharmaceutical industry, Erin built an exceptional academic career as a Doctoral Student at Wayne State University School of Medicine.
Working within the Neuroimaging and Neurorehabilitation Laboratory, her research focused on understanding neurological disorders through advanced imaging, movement science, cognition, and rehabilitation.
Her work explored:
- Multiple sclerosis
- Motor learning
- Functional mobility
- Neurorehabilitation
- Fall risk prediction
- Cognitive neuroscience
- Myelin imaging
- Clinical translation
Her research has resulted in multiple first-author peer-reviewed publications addressing gait impairment, cerebellar dysfunction, neuroimaging, mobility assessment, and rehabilitation strategies for individuals living with Multiple Sclerosis.
These contributions have strengthened scientific understanding while supporting improved approaches to patient care.
Advancing Translational Neuroscience
Earlier in her career, Erin served as Laboratory Manager at the University of New England Center for Excellence in the Neurosciences, where she worked in neuropharmacology research investigating chronic pain, addiction, opioid receptor biology, and therapeutic development.
Her research responsibilities included:
- Pre-clinical pharmacology
- Neuroprotective therapies
- Behavioral neuroscience
- Drug discovery
- Confocal microscopy
- Animal models
- Genotyping
- Experimental design
She also contributed to computational biochemistry research at the University of New England and addiction neuroscience research at the University of Michigan Medical School, building expertise across multiple disciplines that continue to inform her medical affairs leadership today.
A Career Dedicated to Science, Innovation, and Patients
Erin Edwards‘ professional journey reflects a steady progression across research, translational medicine, pharmaceutical innovation, and executive medical leadership.
Her career path includes:
- Student Researcher
- Research Intern
- Laboratory Manager
- Doctoral Research Scientist
- Medical Science Liaison
- Senior Medical Science Liaison
- Associate Medical Director
- Director, US Medical Affairs
Each stage has strengthened her ability to connect scientific discovery with meaningful improvements in patient care.
Shaping the Future of Medical Affairs
As the life sciences industry accelerates innovation across rare diseases, neuroscience, and precision medicine, medical affairs leaders play an increasingly strategic role in translating scientific evidence into clinical impact.
Erin’s leadership philosophy emphasizes:
- Science-first decision making
- Patient-centered innovation
- Evidence-based medicine
- Cross-functional collaboration
- Responsible scientific communication
- Continuous learning
- Healthcare professional engagement
- Research-driven strategy
Her multidisciplinary background uniquely positions her to lead medical organizations navigating increasingly complex therapeutic landscapes.
Looking Ahead
With Erin Edwards serving as Director, US Medical Affairs, Zambon strengthens its ability to deliver scientific excellence across its expanding portfolio of innovative therapies.
Her deep expertise in neuroscience, translational research, medical strategy, evidence generation, and field medical leadership will support the organization’s continued mission of bringing meaningful treatments to patients with complex and underserved medical conditions.
As healthcare continues to evolve through scientific innovation and personalized medicine, Erin’s leadership will help shape stronger collaborations between researchers, clinicians, healthcare providers, and patients.
CXO Gateway Congratulates Erin Edwards
CXO Gateway congratulates Erin Edwards on her appointment as Director, US Medical Affairs at Zambon.
Her remarkable journey–from neuroscience researcher and published scientific author to pharmaceutical medical affairs leader–demonstrates an unwavering commitment to advancing medical science, improving patient outcomes, and fostering innovation in healthcare.
We wish her continued success as she leads Zambon’s U.S. Medical Affairs organization toward new milestones in scientific excellence, rare disease innovation, and patient-centered healthcare leadership.